Getting Lost in the Thicket: AbbVie Wields Its Expansive Humira® Patent Portfolio Against Alvotech’s Adalimumab Biosimilar June 24, 2021
The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II) May 2, 2021
The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I April 12, 2021
Patent Thickets and Regulatory Challenges Cited as Major Factors Limiting Price Reductions in the Biologic Drug Space November 11, 2020
The Federal Circuit Affirms District Court Finding that Sandoz Does Not Infringe Amgen’s Protein Purification Patent June 20, 2019
Pfizer Loses Out On Its Follow-On Petition Challenges to Genentech’s anti-HER2 Patents Because It Did Not Follow General Plastics Guidance September 11, 2018